Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹4,325 Cr
P/E Ratio
--
P/B Ratio
1.76
Industry P/E
54.87
Debt to Equity
0.09
ROE
-2.95 %
ROCE
-1.47 %
Div. Yield
0 %
Book Value
349.19
EPS
13.83
CFO
₹-457.32 Cr
EBITDA
₹175.89 Cr
Net Profit
₹-311.49 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Unichem Lab
| -17.45 | -3.89 | -12.72 | 9.49 | 31.69 | 32.88 | 10.67 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Unichem Lab
| 80.00 | 28.61 | 26.87 | -4.53 | 61.98 | -16.52 | -41.42 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 357.45 | 3,262.45 | 21.37 | 11.93 | |
| 315.95 | 3,444.94 | 65.42 | 24.79 | |
| 775.95 | 3,932.25 | 35.64 | 9.22 | |
| 2,201.80 | 3,634.04 | 45.92 | 23 |
Are these companies really bargains?
2 min read•By Danish Khanna
Top contrary bets by FIIs and DIIs
5 min read•By Rajan Gulati
2 min read•By Yash Rohra
2 min read•By Value Research
4 min read•By Anindya Bera
2 min read•By Research Desk
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology,... psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India. Read more
Incorporated
1962
Chairman
Prakash A Mody
Managing Director
Pabitrakumar Kalipada Bhattacharyya
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Unichem Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Unichem Laboratories Ltd stood at ₹ 3,311 Cr as on 31-Dec-24
The share price of Unichem Laboratories Ltd is ₹613.95 (NSE) and ₹614.35 (BSE) as of 17-Apr-2025 IST. Unichem Laboratories Ltd has given a return of 31.69% in the last 3 years.
Unichem Laboratories Ltd has a market capitalisation of ₹ 4,325 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Unichem Laboratories Ltd is 1.76 times as on 17-Apr-2025, a 30% discount to its peers’ median range of 2.52 times.
Since, TTM earnings of Unichem Laboratories Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Unichem Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Unichem Laboratories Ltd.
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.
The prominent promoters of Unichem Laboratories Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Ipca Laboratories Limited |
52.67%
|
|
Dr. Prakash Amrut Mody |
12.78%
|
|
Anita Prakash Mody |
1.88%
|
|
Supriya Prakash Mody |
1.35%
|
The chairman of the company is Prakash A Mody, and the managing director is Pabitrakumar Kalipada Bhattacharyya.
There is no promoter pledging in Unichem Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
3,932
|
|
|
3,634
|
|
|
3,445
|
|
|
3,262
|
| Unichem Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
4.09
|
|
Operating margin(%)
|
5.2
|
|
Net Margin(%)
|
-1.66
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Unichem Laboratories Ltd was ₹-32 Cr.
₹-9.30
(
